George Ssebyatika

7PUBLICATIONS
73CO-AUTHORS
Major global burdens of diseaseInnate immunityMedical molecular engineering of nucleic acids and proteinsGlycoconjugatesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2025
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice.

George Ssebyatika, Katja Dinkelborg, Luisa J Ströh

|Jun 22, 2024
Viral modulation of type II interferon increases T cell adhesion and virus spread.

Carina Jacobsen, Nina Plückebaum, George Ssebyatika

|May 10, 2024
Targeting cellular cathepsins inhibits hepatitis E virus entry.

Mara Klöhn, Thomas Burkard, Juliana Janzen

|Dec 22, 2022
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination.

Pascal Irrgang, Juliane Gerling, Katharina Kocher

|Sep 26, 2022
Binding of Glycans to the SARS CoV-2 Spike Protein, an Open Question: NMR Data on Binding Site Localization, Affinity, and Selectivity.

Thorben Maass, George Ssebyatika, Marlene Brückner

|Aug 18, 2022
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

Georg M N Behrens, Joana Barros-Martins, Anne Cossmann

Pageof 2